Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Analysis of KLHDC8B in familial nodular lymphocyte predominant Hodgkin lymphoma.

Saarinen S, Vahteristo P, Launonen V, Franssila K, Kivirikko S, Lehtonen R, Bain BJ, Bauduer F, Ünal A, Aaltonen LA, Aittomäki K.

Br J Haematol. 2011 Aug;154(3):413-5. doi: 10.1111/j.1365-2141.2010.08528.x. Epub 2011 Apr 22. No abstract available.

PMID:
21517803
2.

Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma.

Saarinen S, Aavikko M, Aittomäki K, Launonen V, Lehtonen R, Franssila K, Lehtonen HJ, Kaasinen E, Broderick P, Tarkkanen J, Bain BJ, Bauduer F, Ünal A, Swerdlow AJ, Cooke R, Mäkinen MJ, Houlston R, Vahteristo P, Aaltonen LA.

Blood. 2011 Jul 21;118(3):493-8. doi: 10.1182/blood-2011-03-341560. Epub 2011 May 11.

3.

IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma.

Broderick P, Cunningham D, Vijayakrishnan J, Cooke R, Ashworth A, Swerdlow A, Houlston R.

Br J Haematol. 2010 Feb;148(3):413-5. doi: 10.1111/j.1365-2141.2009.07946.x. Epub 2009 Oct 5.

PMID:
19804451
4.

Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells.

Salipante SJ, Mealiffe ME, Wechsler J, Krem MM, Liu Y, Namkoong S, Bhagat G, Kirchhoff T, Offit K, Lynch H, Wiernik PH, Roshal M, McMaster ML, Tucker M, Fromm JR, Goldin LR, Horwitz MS.

Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14920-5. doi: 10.1073/pnas.0904231106. Epub 2009 Aug 12.

5.

Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma.

da Silva GN, Bacchi MM, Rainho CA, de Oliveira DE.

Arch Pathol Lab Med. 2007 Nov;131(11):1691-6.

PMID:
17979488
6.

Familial Hodgkin's lymphoma in Scandinavia.

Jønsson V, Awan H, Nyquist E, Maisenhølder M, Johannesen TB, Ly B, Tjønnfjord GE.

In Vivo. 2011 May-Jun;25(3):431-7.

PMID:
21576419
7.

Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma.

Cordano P, Lake A, Shield L, Taylor GM, Alexander FE, Taylor PR, White J, Jarrett RF.

Br J Haematol. 2005 Feb;128(4):493-5.

PMID:
15686457
9.

T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.

Van Loo P, Tousseyn T, Vanhentenrijk V, Dierickx D, Malecka A, Vanden Bempt I, Verhoef G, Delabie J, Marynen P, Matthys P, De Wolf-Peeters C.

Haematologica. 2010 Mar;95(3):440-8. doi: 10.3324/haematol.2009.009647. Epub 2009 Oct 1.

10.

European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.

Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, van Krieken JM, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V, Stein H.

Blood. 2000 Sep 1;96(5):1889-99.

11.

[Genetic susceptibility of single nucleotide polymorphism in MGMT to non-Hodgkin lymphoma].

Yang F, Shi JY, Xu L, Ren LJ, Zhang QH, Zhao WL, Shen ZX.

Zhonghua Xue Ye Xue Za Zhi. 2009 Sep;30(9):622-5. Chinese.

PMID:
19954624
12.

A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma.

Pratt G, Fenton JA, Allsup D, Fegan C, Morgan GJ, Jackson G, Sunter NJ, Hall AG, Irving JA, Allan JM.

Br J Haematol. 2010 Aug;150(3):371-3. doi: 10.1111/j.1365-2141.2010.08199.x. Epub 2010 Apr 12. No abstract available.

PMID:
20408839
13.

Absence of germline p53 mutations in familial lymphoma.

Weintraub M, Lin AY, Franklin J, Tucker MA, Magrath IT, Bhatia KG.

Oncogene. 1996 Feb 1;12(3):687-91.

PMID:
8637726
14.

IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma.

Cozen W, Gill PS, Ingles SA, Masood R, Martínez-Maza O, Cockburn MG, Gauderman WJ, Pike MC, Bernstein L, Nathwani BN, Salam MT, Danley KL, Wang W, Gage J, Gundell-Miller S, Mack TM.

Blood. 2004 Apr 15;103(8):3216-21. Epub 2003 Dec 30.

15.

Non-Hodgkin malignant lymphomas and Hodgkin's disease in first-degree relatives. Evidence for a mutual genetic predisposition?

Bjerrum OW, Hasselbalch HC, Drivsholm A, Nissen NI.

Scand J Haematol. 1986 Apr;36(4):398-401.

PMID:
3715408
16.

Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma.

Xiong XD, Qiu FE, Fang JH, Shen Y, Liang C, Jiang W, Zhuang SM.

Mutat Res. 2009 Mar 9;662(1-2):10-5. doi: 10.1016/j.mrfmmm.2008.11.014. Epub 2008 Dec 3.

PMID:
19101572
17.

Familial aggregation of Hodgkin lymphoma and related tumors.

Goldin LR, Pfeiffer RM, Gridley G, Gail MH, Li X, Mellemkjaer L, Olsen JH, Hemminki K, Linet MS.

Cancer. 2004 May 1;100(9):1902-8.

18.

Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma.

Stamatoullas A, Picquenot JM, Dumesnil C, Ruminy P, Penther D, Bertrand P, Courel MN, Maisonneuve C, François A, Gaulard P, Tilly H, Bastard C.

Leukemia. 2007 Sep;21(9):2064-7. Epub 2007 May 10. No abstract available.

PMID:
17495968
19.

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.

Boudová L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S, Diehl V, Müller-Hermelink HK, Rüdiger T.

Blood. 2003 Nov 15;102(10):3753-8. Epub 2003 Jul 24.

20.

Methods for testing familial aggregation of diseases in population-based samples: application to Hodgkin lymphoma in Swedish registry data.

Pfeiffer RM, Goldin LR, Chatterjee N, Daugherty S, Hemminki K, Pee D, X LI, Gail MH.

Ann Hum Genet. 2004 Sep;68(Pt 5):498-508.

Supplemental Content

Support Center